Variable | Total (n = 114) n(%) | CRKP (n = 33) n(%) | CSKP (n = 81) n(%) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|---|
OR(95% CI) | p-value | OR(95% CI) | p-value | ||||
General variables | |||||||
Male sex | 74(64.9) | 22(66.7) | 52(64.2) | 1.12(0.5-2.6) | 0.802 | Â | Â |
 Age,years, mean ± SD | 56.37 ± 16.36 | 51.70 ± 16.26 | 58.27 ± 16.11 | NA | 0.051 |  |  |
 Poly-microbial BSI | 11(9.6) | 6(18.2) | 5(6.2) | 3.38 (1.0–12.0) | 0.076 |  |  |
 Nosocomial infection | 98(86.0) | 33(100) | 65(80.2) | NA | 0.005 | - | - |
 ICU acquired infection | 26(22.8) | 14(42.4) | 12(14.8) | 4.24(1.7–10.7) | 0.001 | 5.82(2.0–17.2) | 0.002 |
Comorbidities | |||||||
 Diabetes mellitus | 30(26.3) | 3(9.1) | 27(33.3) | 0.20(0.1–0.7) | 0.008 |  |  |
 Chronic renal failure | 8(7.0) | 3(9.1) | 5(6.2) | 1.52(0.3–6.8) | 0.689 |  |  |
 Chronic liver disease | 20(17.5) | 5(15.2) | 15(18.5) | 0.79(0.3–2.4) | 0.668 |  |  |
 Liver cirrhosis | 11(9.6) | 2(6.1) | 9(11.1) | 0.52(0.1–2.5) | 0.506 |  |  |
 Biliary tract disease | 35(30.7) | 9(27.3) | 26(32.1) | 0.79(0.3–1.9) | 0.612 |  |  |
 Congestive heart failure | 9(7.9) | 4(12.1) | 5(6.2) | 2.10(0.5–8.4) | 0.280 |  |  |
 Chronic obstructive pulmonary disease | 3(2.6) | 1(3.0) | 2(2.5) | 1.23(0.1–14.1) | 1 |  |  |
 Malignancy | 59(51.8) | 12(36.4) | 47(58.0) | 0.41(0.2–1.0) | 0.036 |  |  |
 Immunosuppression | 26(22.8) | 10(30.3) | 16(19.8) | 1.77(0.7–4.4) | 0.223 |  |  |
 CCI,median (IQR) | 3(2–6) | 3(0–4) | 4(2–6) | NA | 0.005 | - | - |
Probable source of infection | |||||||
 Lung | 16(14.0) | 5(15.2) | 11(13.6) | 1.14(0.4–3.6) | 0.776 |  |  |
 Urinary | 1(0.9) | 0(0) | 1(0.9) | NA | 1 |  |  |
 Intra-abdominal | 48(42.1) | 12(36.4) | 36(44.4) | 0.71(0.3–1.6) | 0.428 |  |  |
 Liver abscess | 6(5.3) | 1(3.0) | 5(6.2) | 0.48(0.1–4.2) | 0.671 |  |  |
 Skin and soft tissue | 12(10.5) | 10(30.3) | 2(2.5) | 17.17(3.5–84.0) | <0.001 | 26.63(4.8–146.8) | <0.001 |
 Catheter | 10(8.8) | 5(15.2) | 5(6.2) | 2.71(0.7–10.1) | 0.150 |  |  |
 Primary | 27(23.7) | 5(15.2) | 22(27.2) | 0.48(0.2–1.4) | 0.171 |  |  |
Hospital events prior to onset of BSI | Â | Â | Â | Â | |||
 Exposure to antimicrobial therapy a | 74(64.9) | 30(90.9) | 44(54.3) | 8.41(2.4–29.8) | <0.001 | 4.04(1.0–16.5) | 0.052 |
 Surgery a | 62(54.4) | 21(63.6) | 41(50.6) | 1.71(0.7–3.9) | 0.206 |  |  |
Events on the onset of BSI | Â | Â | Â | Â | Â | Â | Â |
 SOFA score,median (IQR) | 3(1–6) | 4(1–7) | 3(1–5) | NA | 0.098 |  |  |
 PBS,median (IQR) | 1(1-2.25) | 2(1–5) | 1(0–2) | NA | <0.001 | - | - |